logo
Book a meeting
Ophthalmology Innovation Source

Ophthalmology Innovation Source

Media Production, 500 Yale Ave N, Jericho, New York, 98109, United States, 11-50 Employees

ois.net

  • LinkedIn

phone no Phone Number: +19*********

Who is OPHTHALMOLOGY INNOVATION SOURCE

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and c...

Read More

lock icon Get Full Access
map
  • 500 Yale Ave N, Jericho, New York, 98109, United States Headquarters: 500 Yale Ave N, Jericho, New York, 98109, United States
  • 2009 Date Founded: 2009
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Media Production

SIC SIC Code: 6799 | NAICS Code: 523999 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OPHTHALMOLOGY INNOVATION SOURCE

email-formate-icon
View Email Formats for Ophthalmology Innovation Source
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Ophthalmology Innovation Source

Answer: Ophthalmology Innovation Source's headquarters are located at 500 Yale Ave N, Jericho, New York, 98109, United States

Answer: Ophthalmology Innovation Source's phone number is +19*********

Answer: Ophthalmology Innovation Source's official website is https://ois.net

Answer: Ophthalmology Innovation Source's revenue is $5 Million to $10 Million

Answer: Ophthalmology Innovation Source's SIC: 6799

Answer: Ophthalmology Innovation Source's NAICS: 523999

Answer: Ophthalmology Innovation Source has 11-50 employees

Answer: Ophthalmology Innovation Source is in Media Production

Answer: Ophthalmology Innovation Source contact info: Phone number: +19********* Website: https://ois.net

Answer: The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access